Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

2.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.6K
Clinical Trials01:16

Clinical Trials

6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

2.6K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
2.6K
Standards of Care II01:19

Standards of Care II

630
Nurses bear specific legal responsibilities under several federal statutes, including:
630
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Standards of Care I01:22

Standards of Care I

664
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
664

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Comparative Analysis of Lupus Nephritis Guidelines: ACR 2025, EULAR 2025, and Kdigo 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Belimumab in Systemic Lupus Erythematosus: From B-Cell Biology to Disease Modification.

Journal of clinical medicine·2026
Same author

Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

The 2025 KDIGO guideline on the management of nephrotic syndrome in children: a comment of the European Renal Association Immunonephrology Working Group.

Clinical kidney journal·2026
Same author

Prediction model for renal outcomes in Latin American Mestizo patients with pure proliferative lupus nephritis.

Lupus science & medicine·2025
Same journal

Vaccination coverage of influenza and pneumococcal vaccines in patients with rheumatic diseases: a systematic review and meta-analysis.

Rheumatology (Oxford, England)·2026
Same journal

Comment on: Distinct cytokine and cytokine receptor expression patterns characterise different forms of myositis.

Rheumatology (Oxford, England)·2026
Same journal

A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.

Rheumatology (Oxford, England)·2026
Same journal

Cardiac involvement in Behçet's syndrome: findings from a clinically driven cardiological evaluation.

Rheumatology (Oxford, England)·2026
Same journal

Mechanisms, clinical manifestations and management of cardiovascular diseases in ANCA-associated vasculitis.

Rheumatology (Oxford, England)·2026
Same journal

Clinical and autoantibody associations with malignancy in systemic sclerosis: A systematic review and meta-analysis.

Rheumatology (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: May 22, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.7K

Highlights from the plenary session: clinically relevant outcomes.

Luís F Quintana1, Irmgard Neumann2,3

  • 1Glomerular Disease Unit (CSUR), Hospital Clinic Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.

Rheumatology (Oxford, England)
|March 12, 2025
PubMed
Summary
This summary is machine-generated.

Monitoring kidney function markers like creatinine, haematuria, and proteinuria is crucial for predicting outcomes in systemic vasculitis, ANCA glomerulonephritis, and post-transplant patients. This aids in refining prognostication and treatment strategies for better patient management.

Keywords:
AAV-GNTakayasu arteritisanti-GBM-GNclinical phenotypesdisease activity monitoringend-stage kidney diseasekidney transplantation outcomesmortality predictionpersonalized carerelapse prediction

More Related Videos

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

841
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.4K

Related Experiment Videos

Last Updated: May 22, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
14:43

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting

Published on: January 12, 2018

11.7K
Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
05:04

Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training

Published on: August 9, 2024

841
Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care
14:32

Using Visual and Narrative Methods to Achieve Fair Process in Clinical Care

Published on: February 16, 2011

23.4K

Area of Science:

  • Nephrology
  • Rheumatology
  • Immunology

Background:

  • Systemic vasculitis encompasses a group of rare autoimmune diseases characterized by inflammation of blood vessels.
  • Assessing clinically relevant outcomes is vital for improving patient management and treatment strategies in vasculitis.

Purpose of the Study:

  • To highlight the significance of monitoring specific biomarkers for predicting renal outcomes in various vasculitis types.
  • To identify research gaps and future directions in understanding disease progression and treatment efficacy.

Main Methods:

  • Review of findings presented at a plenary session focusing on systemic vasculitis outcomes.
  • Analysis of studies examining renal function markers, intensive care outcomes, frailty, and post-transplant results.

Main Results:

  • Creatinine, haematuria, and proteinuria levels are significant predictors of renal outcomes in vasculitis.
  • Insights into recovery of kidney function in severe ANCA-associated glomerulonephritis and outcomes post-kidney transplantation in anti-GBM disease were discussed.
  • Studies also covered intensive care outcomes in small-vessel vasculitis and the impact of frailty on patient-reported outcomes.

Conclusions:

  • Monitoring key indicators can enhance prognostication and treatment strategies for vasculitis patients.
  • Further research is needed on the predictive role of proteinuria and the influence of clinical phenotypes in Takayasu arteritis.
  • Comprehensive data on intensive care, frailty, and transplantation outcomes provide valuable insights for managing vasculitis.